HaploGNX Revenue

Biotechnology Research • San Diego, California, United States • 1-10 Employees

HaploGNX revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at HaploGNX

Anders Nygren

Founder and CEO

Company overview

Headquarters	6975 Raytheon Rd, 210, San Diego, CA 92111, US
Website	haplognx.com
NAICS	541714
Founded	2019
Employees	1-10
Socials

HaploGNX Email Formats

HaploGNX uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@haplognx.com), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@haplognx.com	100%

About HaploGNX

HaploGNX is a biotechnology company located in San Diego, California. HaploGNX was started by a team of DNA enthusiasts that shared a common goal: To make all the advances from the last several decades of genomics research available to everyone, no matter their gender, race, age or social status. Our first application, the HemoSelect panel for expanded genotyping of red blood cells and platelets, is now available.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

HaploGNX has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

HaploGNX has never raised funding before.

HaploGNX Tech Stack

Discover the technologies and tools that power HaploGNX's digital infrastructure, from frameworks to analytics platforms.

Twitter Emoji

Font scripts

LiteSpeed

Web servers

GeneratePress

WordPress themes

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

MySQL

Databases

RSS

Miscellaneous

Priority Hints

Performance

Frequently asked questions

HaploGNX is located in San Diego, California, US.

HaploGNX generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

HaploGNX has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

HaploGNX was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

HaploGNX has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at HaploGNX

Anders Nygren

Founder and CEO

4.8

40,000 users